Equities analysts expect Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) to announce $685.18 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Calumet Specialty Products Partners, L.P’s earnings. The lowest sales estimate is $665.36 million and the highest is $705.00 million. Calumet Specialty Products Partners, L.P posted sales of $883.80 million in the same quarter last year, which would indicate a negative year over year growth rate of 22.5%. The firm is scheduled to issue its next quarterly earnings results on Thursday, December 27th.

On average, analysts expect that Calumet Specialty Products Partners, L.P will report full-year sales of $3.18 billion for the current financial year, with estimates ranging from $3.11 billion to $3.24 billion. For the next financial year, analysts expect that the firm will report sales of $2.98 billion, with estimates ranging from $2.80 billion to $3.15 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that that provide coverage for Calumet Specialty Products Partners, L.P.

Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) last released its quarterly earnings results on Thursday, August 9th. The oil and gas company reported $0.09 EPS for the quarter, topping the Zacks’ consensus estimate of $0.08 by $0.01. The business had revenue of $945.50 million for the quarter, compared to analyst estimates of $829.99 million. Calumet Specialty Products Partners, L.P had a negative return on equity of 45.02% and a negative net margin of 3.94%.

CLMT has been the topic of a number of research analyst reports. BidaskClub upgraded Calumet Specialty Products Partners, L.P from a “hold” rating to a “buy” rating in a research report on Saturday, July 21st. Zacks Investment Research raised Calumet Specialty Products Partners, L.P from a “hold” rating to a “strong-buy” rating and set a $8.75 price objective on the stock in a report on Friday, July 27th. Finally, ValuEngine downgraded Calumet Specialty Products Partners, L.P from a “hold” rating to a “sell” rating in a report on Monday, August 20th.

NASDAQ CLMT traded down $0.81 during trading hours on Wednesday, reaching $3.86. 928,443 shares of the company’s stock were exchanged, compared to its average volume of 317,729. The firm has a market cap of $370.08 million, a PE ratio of -6.88 and a beta of 1.54. Calumet Specialty Products Partners, L.P has a one year low of $3.79 and a one year high of $9.90. The company has a debt-to-equity ratio of 29.68, a current ratio of 1.45 and a quick ratio of 0.75.

In related news, CFO David West Griffin purchased 11,000 shares of the business’s stock in a transaction dated Wednesday, September 5th. The shares were bought at an average price of $6.57 per share, with a total value of $72,270.00. Following the purchase, the chief financial officer now directly owns 65,405 shares in the company, valued at approximately $429,710.85. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In the last ninety days, insiders have acquired 41,205 shares of company stock worth $269,925. Company insiders own 4.75% of the company’s stock.

Several hedge funds have recently bought and sold shares of CLMT. Eqis Capital Management Inc. acquired a new position in shares of Calumet Specialty Products Partners, L.P in the 2nd quarter valued at $118,000. Stratos Wealth Partners LTD. acquired a new stake in Calumet Specialty Products Partners, L.P during the 3rd quarter worth $148,000. OppenheimerFunds Inc. acquired a new stake in Calumet Specialty Products Partners, L.P during the 2nd quarter worth $298,000. Sumitomo Mitsui Trust Holdings Inc. raised its stake in Calumet Specialty Products Partners, L.P by 87.0% during the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 43,000 shares of the oil and gas company’s stock worth $320,000 after buying an additional 20,000 shares during the period. Finally, Creative Planning raised its stake in Calumet Specialty Products Partners, L.P by 199.3% during the 3rd quarter. Creative Planning now owns 55,565 shares of the oil and gas company’s stock worth $356,000 after buying an additional 37,000 shares during the period. 14.00% of the stock is currently owned by institutional investors.

About Calumet Specialty Products Partners, L.P

Calumet Specialty Products Partners, L.P. produces and sells specialty hydrocarbon products in North America and internationally. It operates in two segments, Specialty Products and Fuel Products. The Specialty Products segment offers various lubricating oils, white mineral oils, solvents, petrolatums, waxes, synthetic lubricants, and other products which are used primarily as raw material components for basic automotive, industrial, and consumer goods.

See Also: What is the balance sheet?

Get a free copy of the Zacks research report on Calumet Specialty Products Partners, L.P (CLMT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Calumet Specialty Products Partners L.P Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet Specialty Products Partners L.P and related companies with MarketBeat.com's FREE daily email newsletter.